NDC 80425-0314-01 - Minocycline hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0314
- Requested NDC
- 80425-0314-01
- Package NDCs from labels
- 80425-0314-1, 80425-0314-2, 80425-0314-3, 80425-0314-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Minocycline hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0314-1 | Minocycline hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0314-2 | Minocycline hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0314-3 | Minocycline hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0314 | MINOCYCLINE HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f901a1ba-1716-8795-e053-6294a90a4e77.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0314-1 | EA - Each | 80425-0314 | 653d204f-3fba-4924-b79e-2cd154f86e4c | 1 | 2023-06-06 |
| 80425-0314-2 | EA - Each | 80425-0314 | bf184420-b29b-4035-bf5b-6dbf31599700 | 1 | 2023-06-06 |
| 80425-0314-3 | EA - Each | 80425-0314 | 14b81cd7-f3d4-4a6a-9de3-430059c885a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 084fb405-fcb9-4db9-8d95-5a9c1d89f3b6 | 2025-07-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 100b48e9-0884-4112-b9aa-cb6f07c28756 | 2025-07-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | dddad9bc-a0a3-41bf-81e5-65d9903b14c6 | 2025-07-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | fb4deae8-23f0-42dd-ac2e-b69ab39a6c4d | 2025-07-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | a0f88292-680b-4d50-ae6e-0a7bccc3a9c6 | 2025-07-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Chartwell RX, LLC | 43fbe7ff-4b67-474d-bf27-e5710d8d10ac | 2025-06-17 | Warnings, Adverse reactions | 0020414E5U |
| minocycline hydrochloride | MINOCYCLINE HYDROCHLORIDE | Zydus Lifesciences Limited | 8bf9cf23-8ffc-401f-981d-4878d694a468 | 2025-06-05 | Warnings, Adverse reactions | 0020414E5U |
| minocycline hydrochloride | MINOCYCLINE HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 85f082a5-bba1-4441-ba28-4b8ec9a537f2 | 2025-06-05 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Actavis Pharma, Inc. | a5fc4d50-50b2-46e0-b722-4c6b2ec47d06 | 2025-06-01 | Warnings, Adverse reactions | 197984 314108 197985 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | ec93ad27-aff5-cbc7-e053-2a95a90adc7e | 2025-05-07 | Warnings, Adverse reactions | ANDA065062 197984 0020414E5U |
| Minocycline hydrochloride | MINOCYCLINE HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 25acb785-6838-4e62-9e86-ddc30b2b759a | 2025-04-26 | Warnings, Adverse reactions | 197984 314108 197985 0020414E5U |
| EMROSI | MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE | Journey Medical Corporation | 0899eb25-8807-037c-f66c-141a2696b1c0 | 2025-04-22 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Aurobindo Pharma Limited | e7b88a48-12b3-461d-b356-0d7ae4e8fd44 | 2025-04-11 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | d00d9bc4-c764-4ec1-beb0-44668637bcfb | 2025-01-28 | Warnings, Adverse reactions | 314108 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1c363cbb-099b-7c73-e063-6394a90ae13f | 2025-01-02 | Warnings, Adverse reactions | ANDA065062 197985 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Aurobindo Pharma Limited | 799a9871-3249-471e-b88d-5d8f7d4b96ad | 2025-01-01 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline hydrochloride | MINOCYCLINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | f901a1ba-1716-8795-e053-6294a90a4e77 | 2024-12-31 | Warnings, Adverse reactions | ANDA065062 80425-0314-1 80425-0314-2 80425-0314-3 80425-0314 80425031401 197984 2a9bad62-b306-697c-e063-6294a90aa395 f901a1ba-1716-8795-e053-6294a90a4e77 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | a6224eeb-25be-4f1d-889f-809aaf338c8c | 2024-10-07 | Warnings, Adverse reactions | 197985 0020414E5U |
| Minocycline hydrochloride | MINOCYCLINE HYDROCHLORIDE | Zydus Lifesciences Limited | 26ee99af-f44b-4076-a08c-0a0dedc9edfe | 2024-10-03 | 197984 314108 197985 0020414E5U | |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 6f154720-706e-4177-8167-1bc893303f1b | 2024-09-04 | Warnings, Adverse reactions | 314108 0020414E5U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.